Non-Myeloablative Allogeneic Transplantation with Post-Transplant Cyclophosphamide after Immune Checkpoint Inhibition for Classic Hodgkin Lymphoma: a Retrospective Cohort Study

BACKGROUND: Immune checkpoint inhibitors (ICIs) are approved in relapsed classic Hodgkin lymphoma (cHL). The safety and effectiveness of allogeneic blood or marrow transplantation (alloBMT) in ICI pretreated cHL patients remain unclear. The aim of this study is to assess outcomes of cHL patients rec...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Biol Blood Marrow Transplant
Main Authors: Paul, Suman, Zahurak, Marianna, Luznik, Leo, Ambinder, Richard F., Fuchs, Ephraim J., Bolaños-Meade, Javier, Wagner-Johnston, Nina, Swinnen, Lode J., Schoch, Laura, Varadhan, Ravi, Jones, Richard J., Gladstone, Douglas E.
Format: Artigo
Sprog:Inglês
Udgivet: 2020
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7486273/
https://ncbi.nlm.nih.gov/pubmed/32592857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2020.06.012
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker